Frontiers in Microbiology,
Год журнала:
2022,
Номер
13
Опубликована: Фев. 10, 2022
The
pandemic
caused
by
the
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
led
to
death
of
millions
people
worldwide
and
thousands
more
infected
individuals
developed
sequelae
due
disease
new
2019
(COVID-19).
development
several
studies
has
contributed
knowledge
about
evolution
SARS-CoV2
infection
forms.
Despite
this
information
being
debated
in
scientific
literature,
many
mechanisms
still
need
be
better
understood
order
control
spread
virus
treat
clinical
cases
COVID-19.
In
article,
we
carried
out
an
extensive
literature
review
bring
together,
a
single
biological,
social,
genetic,
diagnostic,
therapeutic,
immunization,
even
socioeconomic
aspects
that
impact
SAR-CoV-2
pandemic.
This
gathered
article
will
enable
broad
consistent
reading
main
related
current
Abstract
Background
The
emergence
of
the
novel
coronavirus
in
Wuhan,
Hubei
Province,
China,
December
2019
marked
synchronization
world
to
a
peculiar
clock
that
is
counting
infected
cases
and
deaths
instead
hours
minutes.
pandemic,
highly
transmissible
severe
acute
respiratory
syndrome
2
(SARS-CoV-2)
has
indeed
caused
considerable
morbidity
mortality
drastically
changed
our
everyday
lives.
As
we
continue
become
acquainted
with
seventh
known
infect
species,
number
its
characteristics
keep
surprising
us.
Among
those
wide
spectrum
clinical
manifestations
resulting
disease
(COVID-19),
which
ranges
from
asymptomatic
or
mildly
symptomatic
infections
pneumonia,
failure,
death.
Main
body
Data,
now
patient
populations,
are
beginning
accumulate
on
human
genetic
factors
may
contribute
observed
diversified
severity.
Therefore,
deemed
it
prudent
review
associations
between
specific
variants
severity
susceptibility
infection
have
been
reported
literature
date
(at
time
writing
this
article
early
August
2020
updates
mid-September).
With
work,
hope
(i)
assist
fast-paced
biomedical
research
efforts
combat
virus
by
critically
summarizing
current
knowledge
potential
role
host
genetics,
(ii)
help
guide
genetics
genomics
towards
candidate
gene
warrant
further
investigation
larger
studies.
We
found
determinants
differing
COVID-19
predominantly
include
components
immune
response
virus,
while
SARS-CoV-2
mostly
entail
genes
related
initial
stages
(i.e.,
binding
cell
surface
receptor
entry).
Conclusion
Elucidating
would
allow
for
stratification
individuals
according
risk
so
at
high
be
prioritized
immunization,
example,
if
when
safe
effective
vaccines
developed.
Our
enhanced
understanding
underlying
biological
mechanisms
could
also
personalized
therapeutics.
Such
already
provide
clues
explain,
least
part,
epidemiologic
observations
regarding
typically
more
benign
course
older
males
children,
respectively.
EBioMedicine,
Год журнала:
2021,
Номер
72, С. 103629 - 103629
Опубликована: Окт. 1, 2021
The
COVID-19
pandemic
caused
by
the
Severe
Acute
Respiratory
Syndrome
Coronavirus-2
(SARS-CoV-2)
poses
an
unprecedented
challenge
to
humanity.
SARS-CoV-2
infections
range
from
asymptomatic
severe
courses
of
with
acute
respiratory
distress
syndrome
(ARDS),
multiorgan
involvement
and
death.
Risk
factors
for
disease
severity
include
older
age,
male
sex,
increased
BMI
pre-existing
comorbidities.
Ethnicity
is
also
relevant
susceptibility
severity.
Host
genetic
predisposition
now
increasingly
recognized
whole
genome
candidate
gene
association
studies
regarding
have
been
performed.
Several
common
rare
variants
in
genes
related
inflammation
or
immune
responses
identified.
We
summarize
research
on
host
genetics
compile
associated
discuss
that
should
be
investigated
further
understand
such
associations
provide
insights
pathogenesis,
risk
classification,
therapy
response,
precision
medicine,
drug
repurposing.
Frontiers in Immunology,
Год журнала:
2021,
Номер
12
Опубликована: Апрель 1, 2021
Coronavirus
disease
(COVID-19)
presents
a
broad
spectrum
of
clinical
manifestations
ranging
from
an
asymptomatic
to
severe
course.
The
host
genetic
background
influence
on
the
susceptibility
and
outcome
multiples
infectious
diseases
has
been
previously
reported.
Herein,
we
aimed
describe
relevant
identified
variants
those
potentially
related
inter-individual
variability
COVID-19
and/or
severity
considering
physiopathological
pathway
HLA-A*25:01
,
-
B*15:27
-B*46:01
-C*01:02
-C*07:29
alleles
have
associated
with
susceptibility;
while
HLA-A*02:02
-B*15:03
-C*12:03
as
low-risk
alleles.
Variants
in
cytokine
genes
such
IL1B
IL1R1
IL1RN
IL6
IL17A
FCGR2A
TNF
could
be
storm,
complications
(e.g.,
venous
thrombosis).
Several
ACE2
TMPRSS2
affecting
expression
receptors
risk
factors.
Finally,
two
GWAS
loci
3p21.31
(
LZTFL1
SLC6A20
CCR9
FYCO1
CXCR6
XCR1
)
9q34.2
ABO
severity.
Heterogeneous
results
association
were
observed.
mechanism
risk-genes
studies
different
populations
are
still
warranted.
European journal of medical research,
Год журнала:
2021,
Номер
26(1)
Опубликована: Авг. 3, 2021
The
COVID-19
pandemic
has
markedly
impacted
on
cultural,
political,
and
economic
structures
all
over
the
world.
Several
aspects
of
its
pathogenesis
related
clinical
consequences
have
not
yet
been
elucidated.
Infection
rates,
as
well
morbidity
mortality
differed
within
countries.
It
is
intriguing
for
scientists
to
understand
how
patient
genetics
may
influence
outcome
condition,
clarify
which
could
be
variability
SARS-CoV-2
disease.
We
reviewed
studies
exploring
role
human
leukocyte
antigens
(HLA)
genotypes
individual
responses
infection
and/or
progression,
discussing
also
contribution
immunological
patterns
MHC-related.
In
March
2021,
main
online
databases
were
accessed.
All
articles
that
investigated
possible
association
between
HLA
polymorphisms
with
susceptibility,
severity
progression
considered.
Although
both
genetic
environmental
factors
are
certainly
expected
susceptibility
or
protection
individuals,
can
infection.
crucial
played
by
molecules
in
immune
response,
especially
through
pathogen-derived
peptide
presentation,
huge
molecular
alleles
populations
responsible
different
rates
patients
following
iScience,
Год журнала:
2021,
Номер
24(4), С. 102322 - 102322
Опубликована: Март 19, 2021
The
established
risk
factors
of
coronavirus
disease
2019
(COVID-19)
are
advanced
age,
male
sex,
and
comorbidities,
but
they
do
not
fully
explain
the
wide
spectrum
manifestations.
Genetic
implicated
in
host
antiviral
response
provide
for
novel
insights
into
its
pathogenesis.We
performed
an
in-depth
genetic
analysis
chromosome
21
exploiting
genome-wide
association
study
data,
including
6,406
individuals
hospitalized
COVID-19
902,088
controls
with
European
ancestry
from
Host
Genetics
Initiative.
We
found
that
five
single
nucleotide
polymorphisms
within
TMPRSS2
near
MX1
gene
show
associations
severe
COVID-19.
minor
alleles
(SNPs)
correlated
a
reduced
developing
high
level
expression
blood.Our
findings
demonstrate
can
influence
different
clinical
presentations
could
be
potential
therapeutic
target.
Cell Biology International,
Год журнала:
2021,
Номер
45(6), С. 1158 - 1174
Опубликована: Фев. 16, 2021
Since
December
2019,
a
new
form
of
severe
acute
respiratory
syndrome
(SARS)
from
novel
strain
coronavirus
(SARS
2
[SARS-CoV-2])
has
been
spreading
worldwide.
The
disease
caused
by
SARS-CoV-2
was
named
Covid-19
and
declared
as
pandemic
the
World
Health
Organization
in
March
2020.
Clinical
symptoms
range
common
cold
to
more
defined
pneumonia,
hypoxia,
distress.
In
next
stage,
can
become
critical
with
failure,
sepsis,
septic
shock,
and/or
multiorgan
failure.
Outcomes
indicate
large
gaps
between
male-female
young-elder
groups.
Several
theories
have
proposed
explain
variations,
such
gender,
age,
comorbidity,
genetic
factors.
It
is
likely
that
mixture
nongenetic
factors
interplays
virus
host
genetics
determines
severity
outcome.
this
review,
we
aimed
summarize
current
literature
terms
potential
epigenetic
associated
increased
Covid-19.
studies
indicated
variants
entry
mechanism-related
(angiotensin-converting
enzymes,
transmembrane
serine
protease-2,
furin)
innate
immune
response-related
genes
(interferons
[IFNs],
interleukins,
toll-like
receptors),
human
leukocyte
antigen,
ABO,
3p21.31,
9q34.2
loci
are
determinants
related
severity.
Epigenetic
mechanisms
also
affect
outcomes
regulating
IFN
signaling,
angiotensin-converting
enzyme-2,
immunity-related
particularly
escape
X
chromosome
inactivation.
Enhanced
understanding
viral
interactions
for
improved
prognostic
tools
innovative
therapeutics.
Current Opinion in Immunology,
Год журнала:
2022,
Номер
76, С. 102178 - 102178
Опубликована: Март 25, 2022
The
extraordinary
variation
of
the
human
leukocyte
antigen
(HLA)
molecules
is
critical
for
diversifying
presentation
to
T
cells.
Coupled
with
rise
novel
strains
and
rapidly
evolving
immune
evasion
by
SARS-CoV-2
proteins,
HLA-mediated
immunity
in
COVID-19
critically
important
but
far
from
being
fully
understood.
A
growing
number
studies
have
found
association
HLA
variants
different
outcomes
that
genotypes
associate
differential
responses
against
SARS-CoV-2.
Prediction
shown
mutations
multiple
viral
strains,
most
concentrated
Spike
protein,
affect
affinity
between
these
mutant
peptides
molecules.
Understanding
impact
this
on
T-cell
comprehending
immunogenic
mechanisms
both
natural
vaccine
development.
Frontiers in Immunology,
Год журнала:
2021,
Номер
12
Опубликована: Апрель 22, 2021
Severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2),
the
virus
causing
disease
2019
(COVID-19)
was
announced
as
an
outbreak
by
World
Health
Organization
(WHO)
in
January
2020
and
a
pandemic
March
2020.
The
majority
of
infected
individuals
have
experienced
no
or
only
mild
symptoms,
ranging
from
fully
asymptomatic
cases
to
pneumonic
disease.
However,
minority
develop
severe
symptoms.
objective
this
study
identify
susceptible
HLA
alleles
clinical
markers
that
can
be
used
risk
prediction
model
for
early
identification
COVID-19
among
hospitalized
patients.
A
total
137
patients
with
(mCOVID-19)
53
(sCOVID-19)
were
recruited
Center
Hospital
National
Global
Medicine
(NCGM),
Tokyo,
Japan
period
February–August
High-resolution
sequencing-based
typing
eight
genes
performed
using
next-generation
sequencing.
In
association
studies,
HLA-A*11:01:01:01
[P
c
=
0.013,
OR
2.26
(1.27–3.91)]
HLA-C*12:02:02:01-HLA-B*52:01:01:02
0.020,
2.25
(1.24–3.92)]
found
significantly
associated
severity
COVID-19.
After
multivariate
analysis
controlling
other
confounding
factors
comorbidities,
3.34E-03,
3.41
(1.50–7.73)],
age
at
diagnosis
1.29E-02,
1.04
(1.01–1.07)]
sex
birth
8.88E-03,
2.92
(1.31–6.54)]
remained
significant.
area
under
curve
utilizing
HLA-A*11:01:01:01,
diagnosis,
0.772,
sensitivity
0.715
specificity
0.717.
To
best
our
knowledge,
is
first
article
describes
associations
4-field
(highest)
resolution
level.
Early
potential
sCOVID-19
could
help
clinicians
prioritize
medical
utility
decrease
mortality
PLoS ONE,
Год журнала:
2022,
Номер
17(7), С. e0270627 - e0270627
Опубликована: Июль 6, 2022
Although
advanced
age
and
presence
of
comorbidities
significantly
impact
the
variation
observed
in
clinical
symptoms
COVID-19,
it
has
been
suggested
that
genetic
variants
may
also
be
involved
disease.
Thus,
aim
this
study
was
to
perform
a
systematic
review
with
meta-analysis
literature
identify
polymorphisms
are
likely
contribute
COVID-19
pathogenesis.
Pubmed,
Embase
GWAS
Catalog
repositories
were
systematically
searched
retrieve
articles
investigated
associations
between
COVID-19.
For
analyzed
3
or
more
studies,
pooled
OR
95%
CI
calculated
using
random
fixed
effect
models
Stata
Software.
Sixty-four
eligible
included
review.
In
total,
8
7
candidate
genes
74
alleles
HLA
loci
studies.
The
HLA-A*30
CCR5
rs333Del
associated
protection
against
infection,
while
APOE
rs429358C
allele
risk
for
Regarding
severity,
HLA-A*33,
ACE1
Ins,
TMPRSS2
rs12329760T
severe
forms,
HLA-B*38,
HLA-C*6,
ApoE
forms
conclusion,
ApoE,
ACE1,
TMPRSS2,
CCR5,
appear
susceptibility
and/or
severity